171 related articles for article (PubMed ID: 16842132)
1. Cyclooxygenases in cancer: chemoprevention and sensitization to conventional therapies.
Jeon YT; Song YS
Mini Rev Med Chem; 2006 Jul; 6(7):827-33. PubMed ID: 16842132
[TBL] [Abstract][Full Text] [Related]
2. [Cyclooxygenase 2 inhibitors and cancer chemoprevention].
Masmoudi A; Chevalier TL; Sabatier L; Soria JC
Bull Cancer; 2004 May; 91 Suppl 2():S77-84. PubMed ID: 15899630
[TBL] [Abstract][Full Text] [Related]
3. Potential role of selective COX-2 inhibitors in cancer management.
Dang CT; Shapiro CL; Hudis CA
Oncology (Williston Park); 2002 May; 16(5 Suppl 4):30-6. PubMed ID: 12102578
[TBL] [Abstract][Full Text] [Related]
4. Researchers plan to continue to study COX-2 inhibitors in cancer treatment and prevention.
Vanchieri C
J Natl Cancer Inst; 2005 Apr; 97(8):552-3. PubMed ID: 15840872
[No Abstract] [Full Text] [Related]
5. Chemoprevention of colorectal cancer through inhibition of cyclooxygenase-2.
Dannenberg AJ; Zakim D
Semin Oncol; 1999 Oct; 26(5):499-504. PubMed ID: 10528897
[TBL] [Abstract][Full Text] [Related]
6. Cyclooxygenase-2 and epidermal growth factor receptor: pharmacologic targets for chemoprevention.
Dannenberg AJ; Lippman SM; Mann JR; Subbaramaiah K; DuBois RN
J Clin Oncol; 2005 Jan; 23(2):254-66. PubMed ID: 15637389
[TBL] [Abstract][Full Text] [Related]
7. Cyclo-oxygenase 2: a pharmacological target for the prevention of cancer.
Dannenberg AJ; Altorki NK; Boyle JO; Dang C; Howe LR; Weksler BB; Subbaramaiah K
Lancet Oncol; 2001 Sep; 2(9):544-51. PubMed ID: 11905709
[TBL] [Abstract][Full Text] [Related]
8. The role of cyclooxygenase inhibitors in cancer prevention.
Anderson WF; Umar A; Viner JL; Hawk ET
Curr Pharm Des; 2002; 8(12):1035-62. PubMed ID: 11945150
[TBL] [Abstract][Full Text] [Related]
9. Cyclooxygenase inhibition in cancer prevention and treatment.
Anderson WF; Umar A; Hawk ET
Expert Opin Pharmacother; 2003 Dec; 4(12):2193-204. PubMed ID: 14640918
[TBL] [Abstract][Full Text] [Related]
10. Hepatocellular carcinoma: is there a potential for chemoprevention using cyclooxygenase-2 inhibitors?
Koga H
Cancer; 2003 Aug; 98(4):661-7. PubMed ID: 12910508
[TBL] [Abstract][Full Text] [Related]
11. Celecoxib: a potent cyclooxygenase-2 inhibitor in cancer prevention.
Kismet K; Akay MT; Abbasoglu O; Ercan A
Cancer Detect Prev; 2004; 28(2):127-42. PubMed ID: 15068837
[TBL] [Abstract][Full Text] [Related]
12. Cyclooxygenase-2 as a potential target in the prevention and treatment of genitourinary tumors: a review.
Pruthi RS; Derksen E; Gaston K
J Urol; 2003 Jun; 169(6):2352-9. PubMed ID: 12771797
[TBL] [Abstract][Full Text] [Related]
13. COX-2 inhibitors for colorectal cancer.
Elder DJ; Paraskeva C
Nat Med; 1998 Apr; 4(4):392-3. PubMed ID: 9546780
[No Abstract] [Full Text] [Related]
14. COX-2 inhibitors: cancer trials test new uses for pain drug.
Michalowski J
J Natl Cancer Inst; 2002 Feb; 94(4):248-9. PubMed ID: 11854385
[No Abstract] [Full Text] [Related]
15. Chemoprevention of colon cancer by specific cyclooxygenase-2 inhibitor, celecoxib, administered during different stages of carcinogenesis.
Reddy BS; Hirose Y; Lubet R; Steele V; Kelloff G; Paulson S; Seibert K; Rao CV
Cancer Res; 2000 Jan; 60(2):293-7. PubMed ID: 10667579
[TBL] [Abstract][Full Text] [Related]
16. Signal transduction pathways regulating cyclooxygenase-2 expression: potential molecular targets for chemoprevention.
Chun KS; Surh YJ
Biochem Pharmacol; 2004 Sep; 68(6):1089-100. PubMed ID: 15313405
[TBL] [Abstract][Full Text] [Related]
17. Re: Cancer chemoprevention: progress and promise.
Meyskens FL
J Natl Cancer Inst; 1999 Mar; 91(6):563-5. PubMed ID: 10088631
[No Abstract] [Full Text] [Related]
18. Natural Products as Anticancerous Therapeutic Molecules with Special Reference to Enzymatic Targets Topoisomerase, COX, LOX and Aromatase.
Singh S; Awasthi M; Pandey VP; Dwivedi UN
Curr Protein Pept Sci; 2018; 19(3):238-274. PubMed ID: 28059043
[TBL] [Abstract][Full Text] [Related]
19. Is inhibition of cyclooxygenase required for the chemopreventive effect of NSAIDs in colon cancer? A model reconciling the current contradiction.
Rigas B; Shiff SJ
Med Hypotheses; 2000 Feb; 54(2):210-5. PubMed ID: 10790755
[TBL] [Abstract][Full Text] [Related]
20. Enhancing radiotherapy with cyclooxygenase-2 enzyme inhibitors: a rational advance?
Choy H; Milas L
J Natl Cancer Inst; 2003 Oct; 95(19):1440-52. PubMed ID: 14519750
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
